Last week we discussed how PBMs operate within healthcare, including negotiating drug prices and operating clinical programs. And though PBMs are under increasing scrutiny from lawmakers and the FTC, experts argue that reform – not removal – is key to creating a more transparent and efficient system.
Guest Information:
- Eric Levine, Principal, Avalere Health
- Matthew Fielder, Senior Fellow in Economic Studies & in the Center on Health Policy, Brookings Institute
Leave a Reply